Search
Displaying 521–526 of 526 for “Retinitis pigmentosa”
-
Foundation News
Dr. Kelley brings more than 25 years of experience in developing, identifying, and advancing life science technologies to this leadership role at FFB
-
Foundation News
The primary goal of the landmark study, funded by the Foundation, is to provide companies and researchers with disease-progression data and potential clinical trial endpoints to drive therapy development
-
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
Foundation NewsDavid Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
-
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In the PressIn a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
-
FFB Chairman, Gordon Gund, Interviewed on Forbes.com
In the PressThe Foundation’s chairman and co-founder, Gordon Gund is interviewed on Forbes.com
-
Foundation Commits $2 Million to Development of a Cross-Cutting Drug Treatment
NewsMitoChem Therapeutics has identified three compounds that appear to boost mitochondrial function and, thus, show potential for slowing vision loss caused by a variety of retinal degenerations.
- Previous page
- page 1
- page 51
- page 52
- page 53
